For STEC O157:H7, the presence of stx2a in the absence of stx1 predominated amongst all notified STEC O157:H7 cases (55%), as well as severe illness (65%) and HUS (86%) (Figure 7A). Here, STX2 is linked to hemolytic-uremic syndrome.